Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Acute and repeated flibanserin administration in female rats modulates monoamines differentially across brain areas: a microdialysis study.

Allers KA, Dremencov E, Ceci A, Flik G, Ferger B, Cremers TI, Ittrich C, Sommer B.

J Sex Med. 2010 May;7(5):1757-67. doi: 10.1111/j.1743-6109.2010.01763.x. Epub 2010 Feb 12.

PMID:
20163532
2.

Flibanserin, a drug intended for treatment of hypoactive sexual desire disorder in pre-menopausal women, affects spontaneous motor activity and brain neurochemistry in female rats.

Ferger B, Shimasaki M, Ceci A, Ittrich C, Allers KA, Sommer B.

Naunyn Schmiedebergs Arch Pharmacol. 2010 Jun;381(6):573-9. doi: 10.1007/s00210-010-0515-8. Epub 2010 Apr 27.

PMID:
20422156
3.

Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder.

Stahl SM, Sommer B, Allers KA.

J Sex Med. 2011 Jan;8(1):15-27. doi: 10.1111/j.1743-6109.2010.02032.x. Epub 2010 Sep 14. Review.

PMID:
20840530
4.

Chronic systemic administration of serotonergic ligands flibanserin and 8-OH-DPAT enhance HPA axis responses to restraint in female marmosets.

Aubert Y, Bohl MA, Lange JR, Diol NR, Allers KA, Sommer B, Datson NA, Abbott DH.

Psychoneuroendocrinology. 2013 Jan;38(1):145-54. doi: 10.1016/j.psyneuen.2012.05.011. Epub 2012 Jun 21.

PMID:
22727480
5.

Asenapine increases dopamine, norepinephrine, and acetylcholine efflux in the rat medial prefrontal cortex and hippocampus.

Huang M, Li Z, Dai J, Shahid M, Wong EH, Meltzer HY.

Neuropsychopharmacology. 2008 Nov;33(12):2934-45. doi: 10.1038/npp.2008.20. Epub 2008 Apr 16.

6.

ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.

Li Z, Ichikawa J, Huang M, Prus AJ, Dai J, Meltzer HY.

Psychopharmacology (Berl). 2005 Dec;183(2):144-53. Epub 2005 Nov 9.

PMID:
16220333
7.
8.

S-(N, N-diethylcarbamoyl)glutathione (carbamathione), a disulfiram metabolite and its effect on nucleus accumbens and prefrontal cortex dopamine, GABA, and glutamate: a microdialysis study.

Faiman MD, Kaul S, Latif SA, Williams TD, Lunte CE.

Neuropharmacology. 2013 Dec;75:95-105. doi: 10.1016/j.neuropharm.2013.07.007. Epub 2013 Jul 26.

9.

Brain neuronal activation induced by flibanserin treatment in female rats.

Gelez H, Clement P, Compagnie S, Gorny D, Laurin M, Allers K, Sommer B, Giuliano F.

Psychopharmacology (Berl). 2013 Dec;230(4):639-52. doi: 10.1007/s00213-013-3194-6. Epub 2013 Jul 16.

PMID:
23857113
10.

The effects of acetaldehyde on nicotine-induced transmitter levels in young and adult brain areas.

Sershen H, Shearman E, Fallon S, Chakraborty G, Smiley J, Lajtha A.

Brain Res Bull. 2009 Aug 14;79(6):458-62. doi: 10.1016/j.brainresbull.2009.04.005. Epub 2009 Apr 21.

PMID:
19389462
11.

Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters--a rat microdialysis and electrophysiology study.

Pehrson AL, Cremers T, Bétry C, van der Hart MG, Jørgensen L, Madsen M, Haddjeri N, Ebert B, Sanchez C.

Eur Neuropsychopharmacol. 2013 Feb;23(2):133-45. doi: 10.1016/j.euroneuro.2012.04.006. Epub 2012 May 20.

PMID:
22612991
12.

Flibanserin and 8-OH-DPAT implicate serotonin in association between female marmoset monkey sexual behavior and changes in pair-bond quality.

Aubert Y, Gustison ML, Gardner LA, Bohl MA, Lange JR, Allers KA, Sommer B, Datson NA, Abbott DH.

J Sex Med. 2012 Mar;9(3):694-707. doi: 10.1111/j.1743-6109.2011.02616.x. Epub 2012 Feb 3.

PMID:
22304661
13.

Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial.

Goldfischer ER, Breaux J, Katz M, Kaufman J, Smith WB, Kimura T, Sand M, Pyke R.

J Sex Med. 2011 Nov;8(11):3160-72. doi: 10.1111/j.1743-6109.2011.02458.x. Epub 2011 Sep 20.

PMID:
21933348
15.

In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain.

Bortolozzi A, Díaz-Mataix L, Toth M, Celada P, Artigas F.

Psychopharmacology (Berl). 2007 Apr;191(3):745-58. Epub 2007 Jan 30.

PMID:
17265076
16.

Flibanserin for female sexual dysfunction.

Reviriego C.

Drugs Today (Barc). 2014 Aug;50(8):549-56. doi: 10.1358/dot.2014.50.8.2198036.

PMID:
25187905
17.

Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial.

Katz M, DeRogatis LR, Ackerman R, Hedges P, Lesko L, Garcia M Jr, Sand M; BEGONIA trial investigators..

J Sex Med. 2013 Jul;10(7):1807-15. doi: 10.1111/jsm.12189. Epub 2013 May 14.

PMID:
23672269
18.

Efficacy and Safety of Flibanserin in Women with Hypoactive Sexual Desire Disorder: A Systematic Review and Meta-Analysis.

Gao Z, Yang D, Yu L, Cui Y.

J Sex Med. 2015 Nov;12(11):2095-104. doi: 10.1111/jsm.13037. Review.

PMID:
26745616
19.

The 5-HT1A/1B-receptor agonist eltoprazine increases both catecholamine release in the prefrontal cortex and dopamine release in the nucleus accumbens and decreases motivation for reward and "waiting" impulsivity, but increases "stopping" impulsivity.

Korte SM, Prins J, Van den Bergh FS, Oosting RS, Dupree R, Korte-Bouws GA, Westphal KG, Olivier B, Denys DA, Garland A, Güntürkün O.

Eur J Pharmacol. 2017 Jan 5;794:257-269. doi: 10.1016/j.ejphar.2016.11.024. Epub 2016 Nov 17.

PMID:
27866999
20.

Effects of acute and chronic buspirone on impulsive choice and efflux of 5-HT and dopamine in hippocampus, nucleus accumbens and prefrontal cortex.

Liu YP, Wilkinson LS, Robbins TW.

Psychopharmacology (Berl). 2004 Apr;173(1-2):175-85. Epub 2004 Jan 15.

PMID:
14726995

Supplemental Content

Support Center